Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | The importance of survivorship in patients with breast cancer

Tanja Spanic • 13 Mar 2025
BCC 2025
Breast Cancer

Tanja Spanic, PhD, Europa Donna Slovenia, Ljubljana, Slovenia, discusses the significance of patient survivorship after breast cancer diagnosis, and the increase in survival and livelihood. A significant proportion of patients remain active in work and social environments, but continue to face the financial burden of treatment. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Tanja Spanic

Maintaining patient trust in precision medicine for breast cancer
0:32
Maintaining patient trust in precision medicine for breast cancer
Tanja Spanic • 13 Mar 2025
Incorporating patient perspectives into breast cancer trial design
1:12
Incorporating patient perspectives into breast cancer trial design
Tanja Spanic • 13 Mar 2025
Challenges in precision medicine in early-breast cancer
0:44
Challenges in precision medicine in early-breast cancer
Tanja Spanic • 13 Mar 2025
De-escalating treatment of patients with breast cancer
1:31
De-escalating treatment of patients with breast cancer
Tanja Spanic • 17 Mar 2023

Related Videos

ASCENT-04: PFS2 with sacituzumab govitecan and pembrolizumab in PD-L1+ mTNBC
1:12
ASCENT-04: PFS2 with sacituzumab govitecan and pembrolizumab in PD-L1+ mTNBC
Kevin Kalinsky • 31 May 2026
Clinical relevance of PFS2 in metastatic triple-negative breast cancer
1:10
Clinical relevance of PFS2 in metastatic triple-negative breast cancer
Kevin Kalinsky • 31 May 2026
Genomic assays and chemotherapy decisions in node-positive breast cancer
1:35
Genomic assays and chemotherapy decisions in node-positive breast cancer
Kevin Kalinsky • 31 May 2026
ASCENT-07: SG in patients with HER2 IHC0 HR+/HER2- breast cancer
1:30
ASCENT-07: SG in patients with HER2 IHC0 HR+/HER2- breast cancer
Yeon Hee Park • 31 May 2026
The content of VJOncology is intended for healthcare professionals